Clostridial Toxin Pharmaceutical Compositions

Patent No. EP2373294 (titled "Clostridial Toxin Pharmaceutical Compositions") was filed by Allergan on Dec 10, 2009. The application was issued on Apr 20, 2016.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
IPSEN PHARMAJan 18, 2017CABINET PLASSERAUD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2373294

ALLERGAN
Application Number
EP09768315A
Filing Date
Dec 10, 2009
Status
Opposition Rejected
Jul 19, 2024
Publication Date
Apr 20, 2016